“sarepta-therapeutics” Archives

in
Entry Author Date Location
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin 10/14/20 Boston
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies 10/14/20 Boston
Biogen’s AdComm Meeting Will Test FDA’s “Substantial Evidence” Flexibility 10/08/20 Boston
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume 10/01/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor 08/12/20 New York
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs 01/22/20 Boston
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal 12/23/19 Boston
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies 12/16/19 Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug 12/13/19 Boston
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data 07/26/19 Boston
Page 1 of 7 next page »